HRT Financial’s Immunomedics Inc IMMU Stock Holding History

HRT Financial’s Portfolio IMMU Stock Details IMMU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-256,195	Closed	-$21.8M	–	2815
2020 Q3	$21.8M	Buy	256,195 +122,139	+91%	+$6.18M	0.63%	31
2020 Q2	$4.75M	Buy	+134,056	New	+$3.92M	0.14%	130
2019 Q4	–	Sell	-11,108	Closed	-$147K	–	1861
2019 Q3	$147K	Buy	+11,108	New	+$163K	0.01%	1200
2019 Q1	–	Sell	-11,676	Closed	-$166K	–	882
2018 Q4	$166K	Buy	+11,676	New	+$232K	0.02%	497

HRT Financial's IMMU Position: Q4 2020 in Review

HRT Financial sold out of Immunomedics Inc (IMMU) in Q4 2020, closing a stake of 256,195 shares — an estimated $21.8M sold.

HRT Financial first reported a position in IMMU in Q4 2018 and held it in 4 quarters. The position peaked at $21.8M in Q3 2020. 0 funds tracked by Wall St. Rank hold IMMU as of Q4 2020.

HRT Financial reported no remaining Immunomedics Inc position as of Q4 2020 after selling out during the quarter.
HRT Financial sold 256,195 Immunomedics Inc shares in Q4 2020, an estimated $21.8M.
HRT Financial first reported a position in Immunomedics Inc in Q4 2018 and held it in 4 quarters.
HRT Financial's Immunomedics Inc position peaked at $21.8M in Q3 2020.
0 funds tracked by Wall St. Rank held Immunomedics Inc as of Q4 2020.

Based on HRT Financial's 13F filing for Q4 2020, filed 16 Feb 2021.